dehydroxymethylepoxyquinomicin

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedehydroxymethylepoxyquinomicin
Drug Alias NameNFkappaB inhibitors (Keio/Mercian)epoxyquinomicin derivatives (Keio/Mercian)(-)-DHM2EQDHM3EQDHM2EQ +[6] 
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsCachexiaInflammationArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKeio University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKeio UniversityMercian Corp
Active IndicationsN/A
Inactive IndicationsCachexiaInflammationArthritis, Rheumatoid +[4] 

Other Information

ATC CodeN/A
Related LinksN/A